Self-Administration of Augmentation Therapy for Alpha 1-Antitrypsin Deficiency in Italy: a survey study

被引:0
|
作者
Vianello, Andrea [1 ]
Lococo, Sara [1 ]
Corda, Luciano [2 ]
Torrazza, Mario [3 ]
Baderna, Paolo [4 ]
Bargagli, Elena [5 ]
Zamparelli, Stefano Sanduzzi [6 ]
De Marchi, Leonardo Bertagna [1 ]
Molena, Beatrice [1 ]
Lionello, Federico [1 ]
Achille, Alessia [1 ]
Guarnieri, Gabriella [1 ]
机构
[1] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[2] ASST Spedali Civili, Referral Ctr Alpha 1 Antitrypsin Deficiency, Brescia, Italy
[3] AOU Cagliari, Dept Internal Med, Cagliari, Italy
[4] Civil Hosp, Resp Pathophysiol & Ventilat Unit, Saluzzo, Cuneo, Italy
[5] Univ Siena, Dept Med & Surg Sci & Neurosci, Resp Dis Unit, Siena, Italy
[6] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
关键词
D O I
10.1183/13993003.congress-2024.PA3921
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Augmentation therapy in α1-antitrypsin deficiency
    Burdon, JGW
    Brenton, S
    Ayad, M
    Knight, K
    CHEST, 2001, 120 (02) : 687 - 687
  • [2] Augmentation therapy for α1-antitrypsin deficiency
    Juvelekian, GS
    Stoller, JK
    DRUGS, 2004, 64 (16) : 1743 - 1756
  • [3] Augmentation Therapy for α1-Antitrypsin Deficiency
    Georges S. Juvelekian
    James K. Stoller
    Drugs, 2004, 64 : 1743 - 1756
  • [4] Intrapleural Administration of a Second-Generation Oxidation Resistant Alpha 1-Antitrypsin Gene Therapy for Alpha 1-Antitrypsin Deficiency
    Stiles, K. M.
    Sosulski, M. L.
    De, B. P.
    Driscoll, S. R.
    Kaminsky, S. M.
    Crystal, R. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [5] Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α1-antitrypsin
    Piitulainen, E
    Bernspång, E
    Björkman, S
    Berntorp, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (02) : 151 - 156
  • [6] Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human α1-antitrypsin
    Eeva Piitulainen
    Elisabeth Bernspång
    Sven Björkman
    Erik Berntorp
    European Journal of Clinical Pharmacology, 2003, 59 : 151 - 156
  • [7] Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
    Sosulski, Meredith L.
    Stiles, Katie M.
    Frenk, Esther Z.
    Hart, Fiona M.
    Matsumura, Yuki
    De, Bishnu P.
    Kaminsky, Stephen M.
    Crystal, Ronald G.
    JCI INSIGHT, 2020, 5 (15)
  • [8] Alpha 1-antitrypsin deficiency
    Faehndrich, Sebastian
    Bals, Robert
    INNERE MEDIZIN, 2024, : 533 - 537
  • [9] Alpha 1-antitrypsin deficiency
    Rooney, C
    Taggert, C
    O'Neill, SJ
    McElvaney, NG
    Coakley, R
    IRISH MEDICAL JOURNAL, 1999, 92 (01) : 227 - 228
  • [10] Alpha 1-antitrypsin deficiency
    Mornex, J. -F.
    REVUE DES MALADIES RESPIRATOIRES, 2022, 39 (08) : 698 - 707